# Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome

> **NCT00327132** · NA · COMPLETED · sponsor: **National Health Research Institutes, Taiwan** · enrollment: 47 (actual)

## Conditions studied

- Gastric MALT Lymphoma

## Interventions

- **DRUG:** Omeprazole, Amoxicillin, Clarithromycin

## Key facts

- **NCT ID:** NCT00327132
- **Lead sponsor:** National Health Research Institutes, Taiwan
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-03-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00327132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00327132, "Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00327132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*